Literature DB >> 9886963

The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism.

N C Jackson1, P V Carroll, D L Russell-Jones, P H Sönksen, D F Treacher, A M Umpleby.   

Abstract

Net protein loss and large decreases in plasma glutamine concentration are characteristics of critical illness. We have used [2-15N]glutamine and [1-13C]leucine to investigate whole body glutamine and leucine kinetics in a group of critically ill patients and matched healthy controls. Glutamine appearance rate (Ra,Gln) was similar in both groups. However, in the patients, the proportion of Ra,Gln arising from protein breakdown was higher than in the control group (43 +/- 3 vs. 32 +/- 2%, P < 0.05). Glutamine metabolic clearance rate (MCR) was 92 +/- 8% higher (P < 0.001), whereas plasma glutamine concentration was 38 +/- 5% lower (P < 0.001) than in the control group. Leucine appearance rate (whole body proteolysis) and nonoxidative leucine disposal (whole body protein synthesis) were 59 +/- 14 and 49 +/- 15% higher in the patients (P < 0.001). Leucine oxidation and MCR were increased in the patients by 104 +/- 37 and 129 +/- 39%, respectively (P < 0.05). These results demonstrate that critical illness is associated with a major increase in protein turnover. The acute decrease in plasma glutamine concentration and the unaltered plasma Ra,Gln suggest that the increase in proteolysis is insufficient to meet increased demand for glutamine in this severe catabolic state.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886963     DOI: 10.1152/ajpendo.1999.276.1.E163

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Glutamine: a life-threatening deficiency in the critically ill?

Authors:  R D Griffiths; F Andrews
Journal:  Intensive Care Med       Date:  2001-01       Impact factor: 17.440

2.  The effects of acute oral glutamine supplementation on exercise-induced gastrointestinal permeability and heat shock protein expression in peripheral blood mononuclear cells.

Authors:  Micah Zuhl; Karol Dokladny; Christine Mermier; Suzanne Schneider; Roy Salgado; Pope Moseley
Journal:  Cell Stress Chaperones       Date:  2014-07-26       Impact factor: 3.667

3.  Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial.

Authors:  Jaya Benjamin; Govind Makharia; Vineet Ahuja; K D Anand Rajan; Mani Kalaivani; Siddhartha Datta Gupta; Yogendra Kumar Joshi
Journal:  Dig Dis Sci       Date:  2011-10-26       Impact factor: 3.199

4.  Alterations in glutamine metabolism and its conversion to citrulline in sepsis.

Authors:  Christina Kao; Jean Hsu; Venkata Bandi; Farook Jahoor
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-23       Impact factor: 4.310

5.  Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: a pilot study.

Authors:  Menghua Luo; Niloofar Bazargan; Daniel P Griffith; Concepción F Estívariz; Lorraine M Leader; Kirk A Easley; Nicole M Daignault; Li Hao; Jon B Meddings; John R Galloway; Jeffrey B Blumberg; Dean P Jones; Thomas R Ziegler
Journal:  Clin Nutr       Date:  2008-02-07       Impact factor: 7.324

6.  Effect of intravenous GLutamine supplementation IN Trauma patients receiving enteral nutrition study protocol (GLINT Study): a prospective, blinded, randomised, placebo-controlled clinical trial.

Authors:  Ruqaiya M Al Balushi; Jennifer D Paratz; Jeremy Cohen; Merrilyn Banks; Joel Dulhunty; Jason A Roberts; Jeffrey Lipman
Journal:  BMJ Open       Date:  2011-11-14       Impact factor: 2.692

Review 7.  Metabolic and nutritional support of critically ill patients: consensus and controversies.

Authors:  Jean-Charles Preiser; Arthur R H van Zanten; Mette M Berger; Gianni Biolo; Michael P Casaer; Gordon S Doig; Richard D Griffiths; Daren K Heyland; Michael Hiesmayr; Gaetano Iapichino; Alessandro Laviano; Claude Pichard; Pierre Singer; Greet Van den Berghe; Jan Wernerman; Paul Wischmeyer; Jean-Louis Vincent
Journal:  Crit Care       Date:  2015-01-29       Impact factor: 9.097

Review 8.  Could Exogenous Insulin Ameliorate the Metabolic Dysfunction Induced by Glucocorticoids and COVID-19?

Authors:  Martin Brunel Whyte; Prashanth R J Vas; Anne M Umpleby
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

9.  A tracer bolus method for investigating glutamine kinetics in humans.

Authors:  Maiko Mori; Marie Smedberg; Maria Klaude; Inga Tjäder; Ake Norberg; Olav Rooyackers; Jan Wernerman
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

10.  Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation.

Authors:  Maiko Mori; Olav Rooyackers; Marie Smedberg; Inga Tjäder; Ake Norberg; Jan Wernerman
Journal:  Crit Care       Date:  2014-04-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.